Effect of tolcapone, a catechol-O-methyltransferase inhibitor, on striatal dopaminergic transmission during blockade of dopamine uptake

By Budygin E.A.   Gainetdinov R.R.   Kilpatrick M.R.   Rayevsky K.S.   Mannisto P.T.   Wightman R.M.  

European Journal of Pharmacology, Vol. 370, Iss. 2, 1999-04 ,pp. : 125-131

Elsevier

Access to resources Recommend Favorite

Absence of detectable striatal dopamine D 4 receptors in drug-treated schizophrenia

By Reynolds G.P.   Mason S.L.  

European Journal of Pharmacology, Vol. 281, Iss. 2, 1995-08 ,pp. : 5-6

Elsevier

Access to resources Recommend Favorite

Effect of antidepressants on striatal and accumbens extracellular dopamine levels

By Ichikawa J.   Meltzer H.Y.  

European Journal of Pharmacology, Vol. 281, Iss. 3, 1995-08 ,pp. : 255-261

Elsevier

Access to resources Recommend Favorite

Determination of the effects of caffeine and carbamazepine on striatal dopamine release by in vivo microdialysis

By Okada M.   Kiryu K.   Kawata Y.   Mizuno K.   Wada K.   Tasaki H.   Kaneko S.  

European Journal of Pharmacology, Vol. 321, Iss. 2, 1997-02 ,pp. : 181-188

Elsevier

Access to resources Recommend Favorite

Barakol, a natural anxiolytic, inhibits striatal dopamine release but not uptake in vitro

By Thongsaard W.   Pongsakorn S.   Sudsuang R.   Bennett G.W.   Kendall D.A.   Marsden C.A.  

European Journal of Pharmacology, Vol. 319, Iss. 2, 1997-01 ,pp. : 157-164

Elsevier

Access to resources Recommend Favorite